COMPANY RESEARCH
Medacta Group SA
MOVE.SW · Switzerland · Healthcare · Medical Devices
INSIDER SIGNAL
Buyers not named in the filings · 15 purchase line(s) · €1.60m net purchases
Europe #407 · Switzerland #17
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
How many distinct insiders bought in the cluster
Purchase value relative to company size and liquidity
The seniority and relevance of participating insiders
How recently the purchases occurred
How clearly buying stands out from other activity
What is holding the score back?
- ⚠ Buyer breadth is moderate · fewer than 4 distinct filers
- ⚠ Purchase activity is becoming less recent
- ✓ Strong insider role · c-suite involved
The role contribution uses the inverted role input of the current European model.
Buying concentration
The filings do not name the buyer, so who bought how much cannot be worked out.
This is a ranking under the current European screening rules—not a probability of gain, return forecast, or buy recommendation.
Key purchase quotes (filing currency)
| Filer | Price per unit | Trade date |
|---|---|---|
| — | 113.2–114 CHF | Oct 2, 2026 |
| — | 114.4 CHF | Oct 1, 2026 |
| — | 112.943457 CHF | Sep 21, 2026 |
Model details
Cluster breakdown (does not change the score)
Not measured: the scoring window holds no purchase filing with both a buyer name and a trade date.
What the filings show
- 🟢 Recent eligible purchase
— · 199k CHF · Price 113.2–114 CHF · Oct 2, 2026 - 🟢 PDMR purchase
— · 100k CHF · Price 114.4 CHF · Oct 1, 2026 - 🟢 PDMR purchase
— · 516k CHF · Price 112.943457 CHF · Sep 21, 2026 - 🟡 11 remaining qualified transaction line(s) across 11 disclosure(s)
- 🔴 7 other transaction line(s) are not counted as discretionary-buying evidence; 0 have zero price
Insider vs stock price
12 purchase day(s), 15 purchase line(s) in the 180-day window. 4 sale day(s), 4 sale line(s).
Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.
If you had followed the purchase
Each row starts on the first close on or after the day a purchase was made public, the earliest a reader could have acted, and ends on the last close shown above.
| Made public | Insiders | In this stock, now | In the median peer stock, now | Difference |
|---|---|---|---|---|
| 2026-04-27 | 1 | 753 −24.7% | 985 −1.5% | −232 −23.2 pts |
| 2026-05-08 | 1 | 814 −18.6% | 1,001 +0.1% | −187 −18.7 pts |
| 2026-06-02 | 1 | 805 −19.5% | 996 −0.4% | −191 −19.1 pts |
| 2026-09-10 | 1 | 982 −1.8% | 997 −0.3% | −15 −1.5 pts |
| 2026-09-17 | 1 | 1,047 +4.7% | 1,000 +0.0% | +47 +4.7 pts |
| 2026-09-18 | 1 | 1,046 +4.6% | 993 −0.7% | +53 +5.3 pts |
| 2026-09-21 | 1 | 1,030 +3.0% | 993 −0.7% | +37 +3.7 pts |
| 2026-09-22 | 1 | 1,010 +1.0% | 987 −1.3% | +23 +2.3 pts |
| 2026-09-23 | 1 | 1,008 +0.8% | 990 −1.0% | +18 +1.8 pts |
| 2026-09-29 | 1 | 997 −0.3% | 987 −1.3% | +10 +1.0 pts |
| 2026-10-01 | 1 | 1,015 +1.5% | 1,000 +0.0% | +15 +1.5 pts |
| 2026-10-02 | 1 | 1,018 +1.8% | 998 −0.2% | +20 +2.0 pts |
8 of 12 disclosure day(s) ended ahead of the median peer stock.
Close to close, before costs, taxes, dividends and currency moves. The peer is the median of the other stocks on the same exchange for which this site holds prices (91 here), not an index. This is what happened, not a forecast: across all purchases on this site the typical gap is close to zero.
Insider timeline
One insider bought, 12 times, the latest (2 Oct). The share closed at 119.76 that day and at 121.88 most recently (+1.8%). 1 of the buyers also disclosed a sale in the window.
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
×A sale
A cross is one insider's sales on one day. People sell to pay tax, to cash in share awards or to hold less of one company, so a sale says less than a purchase does. When someone bought and sold on the same day, the cross sits beside the dot. The totals are under “Purchases against sales” below.
Blue line: this share's price, −28.5% over these six months
The closing price of each day, from 170.40 on 2026-04-21 to 121.88 on 2026-10-07. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −0.6%
Taken from the 89 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −28.5%, the typical one −0.6%, 27.9 points behind. It is not an index and not a comparison within one industry.
▂Grey bars: companies across Europe disclosing purchases each week
A taller bar is a week in which more companies disclosed insider purchases.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since | Earlier purchases |
|---|---|---|---|---|---|---|---|
| Unknown insider | Board member | 12 | 4 | 2.3M CHF | 2026-04-27 | −24.7% | fewer than 5 completed |
Purchases against sales
Shares of the reported value of insider transactions in the 180-day window. Sales include disposals for tax, at option exercise or under a pre-set plan, which say little about an insider's view. The split describes what was disclosed; it is not a signal.
Why this score? · Model details
Priority = 100 × Σ(fixed weight × 0–1 rule-based input)
| Factor | Weight | This company input | Point contribution |
|---|---|---|---|
| 15-day buyer breadth (count) | 35% | 0.496; source unavailable, filled with a cohort-neutral value | 17.4 |
| Qualified-buy size | 25% | 0.926 | 23.2 |
| Role informativeness (inverted) | 20% | 0.250 | 5.0 |
| Recency | 10% | 0.354 | 3.5 |
| Buy/sell conviction | 10% | 0.736 | 7.4 |
This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.
BULL VS BEAR
Two readings of this buying
The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.
Since 2026-10-13: no longer on the bull side: large purchases, bought in the last two weeks. All bull and bear lists, and what followed each line in the past →
Where the evidence comes from
Independent evidence does not object: the purchases themselves carry bull lines (senior executive buying); company results were checked and none crosses a bear threshold. No data is held for: share price and trading, short sellers, company actions.
- The insider purchases themselvesBullsenior executive buying Bearinsiders also sold2 checked, under the threshold · 3 missing
- Share price and tradingno data held
- Short sellers1 missing
- Company results1 checked, under the threshold · 1 missing
- Company actionsno data held
Bull case · the buying is informative
- The buyers include a senior executive, who sees more of the business than most filers. This site's score gives little or no credit for that: in its backtests purchases by senior executives did no better than other insiders' purchases.Record: after 8,797 earlier disclosures like this, the median 60-session excess return was −3.1%, within 1 percentage point of all comparable disclosures (−3.2%).
Bear case · discount it
- Insiders also sold €894k in the same 180 days, 36% of the amount bought.
Evidence still missing
- This register does not name the filer, so the 15 purchase lines may come from one person or from several. Breadth of buying cannot be judged.
- Only one reading of profitability is held (profit margin 11%). Whether earnings and cash flow are rising or falling needs the last two reports side by side.
- This company's market publishes no register of net short positions (it is outside the EU Short Selling Regulation), so whether professional investors are positioned against the buying cannot be read from a public source.
- European notifications have no field saying whether a purchase was pre-arranged; there is no counterpart to the US 10b5-1 box. None of the 15 purchase lines mentions a plan, but a bare “Purchase” does not rule one out.
- The filings give the size of each trade, not what the buyer already held. Whether a purchase added 1% to a personal stake or doubled it is not known.
Checked and under the threshold: 3, 1 close to it
- EitherThe latest purchase is 15 days old. Bull up to 14 days, bear from 90. close to the threshold
- EitherNet purchases equal 0.06% of the company's market value. Bull from 0.10%, bear below 0.01%.
- BearProfit margin on the latest captured figures is 11%. Counted for the bear side when negative.
Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.
Signal history
Latest recorded score
- Recorded snapshots
- 21
- First snapshot
- 2026-09-23
There is not yet a 30-calendar-day comparison; earlier scores are not reconstructed. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.
Why did it change?
Less than 30 days of comparable history is available, so factor movement is not yet decomposed.
Signal score history
Fixed 0–100 scale; dates are spaced by calendar time.
Recent recorded points
- 60.9
- 61.1
- 60.6
- 57.5
- 56.4
View all recorded scores
| Snapshot date | Signal score |
|---|---|
| 2026-09-23 | 60.9 |
| 2026-09-24 | 61.2 |
| 2026-09-25 | 60.6 |
| 2026-09-28 | 58.9 |
| 2026-09-29 | 58.1 |
| 2026-09-30 | 61.1 |
| 2026-10-01 | 60.5 |
| 2026-10-02 | 61.4 |
| 2026-10-03 | 61.4 |
| 2026-10-04 | 61.4 |
| 2026-10-05 | 60.6 |
| 2026-10-06 | 60.1 |
| 2026-10-07 | 59.6 |
| 2026-10-08 | 59.1 |
| 2026-10-09 | 58.7 |
| 2026-10-12 | 57.5 |
| 2026-10-13 | 57.6 |
| 2026-10-14 | 57.2 |
| 2026-10-15 | 56.9 |
| 2026-10-16 | 56.6 |
| 2026-10-18 | 56.4 |
Sector context
- Buying breadth
- 6.1% (48 / 792 issuers)
- Sector rank
- #11 / 12
- 7D breadth change
- -0.4 pp · vs 2026-10-12 (6d)
- 30D breadth change
- History building
This is sector-level research context. It does not affect the Insider Signal or ranking.
Insider profile outcomes
The filings for this company do not name the buyer, so past purchases cannot be followed person by person.
Market context
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- Volatility
- —
- Beta
- 1.01
- Avg daily volume
- —
VALUATION
- Market cap
- CHF 2.3B
- P/E
- 32.4×
FUNDAMENTALS
- Profit margin
- 10.9%
- ROE
- 17.0%
- Industry
- Medical Devices
Prices to 16 Oct 2026: OpenBB/yfinance. From OpenBB/yfinance, captured 16 Oct 2026: Market cap, P/E, Profit margin, ROE, Beta, Industry. It does not affect the insider score or rank.
Disclosed net short positions
This country's register of net short positions was not read for this build. That says nothing about whether short positions exist.
Insiders' buying price vs the latest close
The latest close in the price history is more than a week old.
Buying size vs market trading
Market history is too old for this snapshot; ratios are withheld.
Market-data coverage: 245 verified sessions · Latest session: 2026-10-07 · Ratio status: Unavailable
Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.
Latest news
No news has been captured for this company.
Regulatory filings
The filing records held for this company carry no link to the original notice.
Filing evidence
These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.
Excluded transactions & classification
17 qualifying purchase disclosure(s) · 17 transaction line(s)
Unfold all 14 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | — | Member of the board of directors | Purchase | Share | 116.0 CHF | CHF | 870.0 | — |
| 2026-09-23 | 2026-09-23 | — | Member of the board of directors | Purchase | Share | 115.0 CHF | CHF | 875.0 | — |
| 2026-09-22 | 2026-09-22 | — | Member of the board of directors | Purchase | Share | 113.8 CHF | CHF | 875.0 | — |
| 2026-09-21 | 2026-09-21 | — | Member of the board of directors | Purchase | Share | 112.94345733041575 CHF | CHF | 4570.0 | — |
| 2026-09-21 | 2026-09-21 | — | Member of the executive management | Purchase | Share | 112.71730434782609 CHF | CHF | 2300.0 | — |
| 2026-09-18 | 2026-09-18 | — | Member of the board of directors | Purchase | Share | 109.72167235494881 CHF | CHF | 1758.0 | — |
| 2026-09-17 | 2026-09-17 | — | Member of the board of directors | Purchase | Share | 109.69107396870554 CHF | CHF | 2812.0 | — |
| 2026-09-17 | 2026-09-17 | — | Member of the executive management | Purchase | Share | 109.81982608695652 CHF | CHF | 2300.0 | — |
| 2026-09-10 | 2026-09-10 | — | Member of the board of directors | Purchase | Share | 118.0 CHF | CHF | 165.0 | — |
| 2026-06-02 | 2026-06-02 | — | Member of the board of directors | Purchase | Share | 136.0 CHF | CHF | 110.0 | — |
| 2026-05-08 | 2026-05-08 | — | Member of the board of directors | Purchase | Share | 138.0 CHF | CHF | 207.0 | — |
| 2026-04-27 | 2026-04-27 | — | Member of the board of directors | Purchase | Share | 147.6 CHF | CHF | 813.0 | — |
| 2026-03-23 | 2026-03-23 | — | Member of the board of directors | Purchase | Share | 148.0 CHF | CHF | 730.0 | — |
| 2025-11-07 | 2025-11-07 | — | Member of the board of directors | Purchase | Share | 140.2 CHF | CHF | 2500.0 | — |
Showing 17 of 17 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Other disclosed transactions · excluded from score
View 15 other transaction(s)
Unfold all 12 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 2026-05-15 | — | Member of the board of directors | Sale | Share | 137.6 CHF | CHF | 219.0 | — |
| 2026-05-05 | 2026-05-05 | — | Member of the executive management | Purchase (Zuteilung — SIX size-unknown-at-filing placeholder) | Share | 60000.0 CHF | CHF | 1.0 | — |
| 2026-05-05 | 2026-05-05 | — | Member of the executive management | Purchase (Zuteilung — SIX size-unknown-at-filing placeholder) | Share | 52000.0 CHF | CHF | 1.0 | — |
| 2026-05-05 | 2026-05-05 | — | Member of the executive management | Purchase (Zuteilung — SIX size-unknown-at-filing placeholder) | Share | 22000.0 CHF | CHF | 1.0 | — |
| 2026-04-15 | 2026-04-15 | — | Member of the board of directors | Sale | Share | 163.6 CHF | CHF | 730.0 | — |
| 2025-12-19 | 2025-12-19 | — | Member of the board of directors | Sale | Share | 151.57801073894143 CHF | CHF | 3911.0 | — |
| 2025-12-19 | 2025-12-19 | — | Member of the board of directors | Sale | Share | 152.0 CHF | CHF | 3100.0 | — |
| 2025-12-19 | 2025-12-19 | — | Member of the board of directors | Sale | Share | 151.6687594173782 CHF | CHF | 1991.0 | — |
| 2025-12-16 | 2025-12-16 | — | Member of the board of directors | Sale | Share | 153.08353846153847 CHF | CHF | 2600.0 | — |
| 2025-12-01 | 2025-12-01 | — | Member of the board of directors | Sale | Share | 155.0 CHF | CHF | 1250.0 | — |
| 2025-11-13 | 2025-11-13 | — | Member of the board of directors | Sale | Share | 156.2 CHF | CHF | 800.0 | — |
| 2025-10-28 | 2025-10-28 | — | Member of the board of directors | Sale | Share | 147.6 CHF | CHF | 670.0 | — |
Showing 15 of 15 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Snapshot & identity
- Snapshot date
- 2026-10-18
- Ticker
- MOVE.SW
- ISIN
- CH0468525222
- Sector
- Healthcare
- Industry
- Medical Devices
Company logos by Parqet